AGP
Aspire Growth Partners Portfolio holdings
AUM
$122M
This Quarter Return
-2.53%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$113M
AUM Growth
+$113M
(+10%)
Cap. Flow
+$15M
Cap. Flow
% of AUM
13.29%
Top 10 Holdings %
Top 10 Hldgs %
44.69%
Holding
116
New
17
Increased
67
Reduced
27
Closed
3
Top Buys
| 1 |
Capital Group Core Equity ETF
CGUS
|
$2.1M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
$1.79M |
| 3 |
Trane Technologies
TT
|
$1.12M |
| 4 |
Eaton
ETN
|
$1.03M |
| 5 |
Capital Group Dividend Value ETF
CGDV
|
$925K |
Top Sells
| 1 |
IQVIA
IQV
|
$241K |
| 2 |
Thermo Fisher Scientific
TMO
|
$219K |
| 3 |
Bristol-Myers Squibb
BMY
|
$208K |
| 4 |
iShares MSCI USA Momentum Factor ETF
MTUM
|
$99.2K |
| 5 |
Nucor
NUE
|
$90.5K |
Sector Composition
| 1 | Technology | 18.81% |
| 2 | Financials | 6.96% |
| 3 | Healthcare | 5.89% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Industrials | 5.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Edwards Lifesciences
EW
$47.9B
| $238K | 0.21% |
3,171
-28
| -0.9% | -$2.1K |
|
102
Capital Group Global Growth Equity ETF
CGGO
$6.79B
| $233K | 0.21% |
+8,012
| New | +$233K |
|
103
AutoZone
AZO
$69.7B
| $232K | 0.21% |
+62
| New | +$232K |
|
104
Raymond James Financial
RJF
$33.5B
| $231K | 0.21% |
1,613
+11
| +0.7% | +$1.58K |
|
105
BP
BP
$90.8B
| $224K | 0.2% |
+7,955
| New | +$224K |
|
106
Progressive
PGR
$144B
| $217K | 0.19% |
+758
| New | +$217K |
|
107
Amplify CWP Enhanced Dividend Income ETF
DIVO
$4.98B
| $215K | 0.19% |
+5,320
| New | +$215K |
|
108
Howmet Aerospace
HWM
$69.7B
| $213K | 0.19% |
+1,354
| New | +$213K |
|
109
NextEra Energy, Inc.
NEE
$149B
| $212K | 0.19% |
3,143
+337
| +12% | +$22.7K |
|
110
Qualcomm
QCOM
$169B
| $203K | 0.18% |
1,407
+101
| +8% | +$14.6K |
|
111
Chipotle Mexican Grill
CMG
$56B
| $201K | 0.18% |
3,897
-7
| -0.2% | -$361 |
|
112
Nuveen Preferred & Income Opportunities Fund
JPC
$2.6B
| $92.1K | 0.08% |
+11,773
| New | +$92.1K |
|
113
CytomX Therapeutics
CTMX
$340M
| $88.6K | 0.08% |
92,254
+51,474
| +126% | +$49.4K |
|
|
114
Bristol-Myers Squibb
BMY
$96.4B
| – | – |
-3,684
| Closed | -$208K |
|
|
115
IQVIA
IQV
$31.3B
| – | – |
-1,226
| Closed | -$241K |
|
|
116
Thermo Fisher Scientific
TMO
$183B
| – | – |
-421
| Closed | -$219K |
|